Similar articles

• The TSH, T4, T3 and prolactin responses to consecutive infusions of a potent and stabilized thyrotrophin releasing hormone analogue, RX77368, in man.

  Eckland DJ, Lightman SL. Eckland DJ, et al. Eur J Clin Invest. 1988 Aug;18(4):405-9. doi: 10.1111/j.1365-2362.1988.tb01031.x. Eur J Clin Invest. 1988. PMID: 2844546 Clinical Trial.
• Comparative efficacy and safety of intravenous and oral administration of a TRH analogue (RX77368) in motor neuron disease.

  Modarres-Sadeghi H, Guiloff RJ. Modarres-Sadeghi H, et al. J Neurol Neurosurg Psychiatry. 1990 Nov;53(11):944-7. doi: 10.1136/jnnp.53.11.944. J Neurol Neurosurg Psychiatry. 1990. PMID: 2126554 Free PMC article. Clinical Trial.
• Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.

  Sarne DH, Sobieszczyk S, Ain KB, Refetoff S. Sarne DH, et al. J Clin Endocrinol Metab. 1990 May;70(5):1305-11. doi: 10.1210/jcem-70-5-1305. J Clin Endocrinol Metab. 1990. PMID: 2110573
• Observations on the clinical assessment of patients with motor neuron disease. Experience with a TRH analogue.

  Guiloff RJ, Eckland DJ. Guiloff RJ, et al. Neurol Clin. 1987 Feb;5(1):171-92. Neurol Clin. 1987. PMID: 3104752 Review.
• Use of TRH analogues in motorneurone disease.

  Guiloff RJ. Guiloff RJ. Ann N Y Acad Sci. 1989;553:399-421. doi: 10.1111/j.1749-6632.1989.tb46662.x. Ann N Y Acad Sci. 1989. PMID: 2497683 Review.